Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations

Molecular Genetics and Metabolism

Volumn 68, Issue 4, 1999, Pages 419-423

  Gatti, Richard A ^a   Tward, Aaron ^b   Concannon, Patrick ^c,d  

^a Department of Pathology ^*  (United States)

^b Depts Med Microbiol/Med Genet   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Ataxia telangiectasia; Cancer risk; Genotype phenotype correlations; Heterozygotes; Model; Mutations

Indexed keywords

GENE PRODUCT;

ATAXIA TELANGIECTASIA; CANCER RISK; CLINICAL FEATURE; DNA DETERMINATION; GENE FREQUENCY; GENE MUTATION; HETEROZYGOTE; HUMAN; PATIENT CODING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK ASSESSMENT; SHORT SURVEY;

EID: 0033380655     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2942     Document Type: Article

References (32)

1. Gatti RA. Ataxia-telangiectasia. In The Genetic Basis of Human Cancer (Vogelstein B, Kinzler KW, Eds.). New York: McGraw-Hill, Inc., pp 275-300, 1998.
2. Swift A, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. New Engl J Med 325:1831-1836, 1991.
3. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130-134, 1996.
4. Lange E, Borresen A-L, Chen X, Chessa L, Chiplunkar S, Concannon P, Dandekar S, Gerken S, Lange K, Liang T, McConville C, Polakow J, Porras O, Rotman G, Sanal O, Sheikhavandi S, Shiloh Y, Sobel E, Taylor M, Telatar M, Teraoka S, Tolun A, Udar N, Uhrhammer N, Vanagaite L, Wang Z, Wapelhorst B, Yang H-M, Yang L, Ziv Y, Gatti RA. Localization of an ataxia-telangiectasia gene to a ∼500 kb interval on chromosome I11q23.1: Linkage analysis of 176 families in an international consortium. Am J Hum Genet 57:112-119, 1995.
5. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor MR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995.
6. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster DB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M. The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56:2726-2732, 1996.
7. Vorechovsky I, Luo L, Lindblom A, Negrini M, Webster DB, Croce CM, Hammarstrom L. ATM mutations in cancer families. Cancer Res 56:4130-4133, 1996.
8. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet 15:307-310, 1997.
9. Bay J-O, Grancho M, Pernin D, Presneau N, Rio P, Tchirkov A, Uhrhammer N, Verrelle P, Gatti RA, Bignon Y-J. No evidence for constitutional ATM mutation in breast/gastric cancer families. Int J Oncol 12:1385-1390, 1998.
10. Chen J, Birksholtz GC, Lindblom P, Rubio C, Lindblom A. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 58:1376-1379, 1998.
11. Shafman TD, Levitz S, Nixon AJ, Gibans L-A, Nichols KE, Bell DW, Ishioka C, Isselbacher KJ, Gelman R, Garber J, Harris JR, Haber DA. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes, Chromosomes Cancer, in press.
12. Bishop DT, Hopper J. AT-tributable risks? Nature Genet 15:226-227, 1997.
13. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers MGJ, Gatti RA, Lenoir G, Lavin M, Tatsumi K, Wegner RD, Shiloh Y, Bar-Shira A. Predominance of null mutation in ataxia-telangiectasia. Hum Mol Genet 5:433-439, 1996.
14. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, Concannon P, Good RA, Gatti RA. Ataxia-telangiectasia: Mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59:40-44, 1996.
15. Telatar M, Wang Z, Castellvi-Bel S, Tai L-Q, Sheikhavandi S, Regueiro JG, Porras O, Gatti RA. A model for ATM heterozygote identification in a large population: Four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia. Mol Genet Metabol 64: 36-43, 1998.
16. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Talyor AMR. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345, 1998.
17. Concannon P, Gatti RA. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat 10:100-107, 1997.
18. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Dohner H. Evidence for ATM as a tumor suppressor gene in T-prolymphocytic leukemia. Nature Med 3:1155-1161, 1997.
19. Yuille MR, Colgnet LJ, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Verechovsky I, Dyer MJ, Catovsky D. ATM is usually rearranged in T-cell prolymphocytic leukemia. Oncogene 16:789-796, 1998.
20. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC, Croce C. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59:24-27, 1999.
21. Stankovic T, Weber P, Stewart G, Bedenham T, Byrd PJ, Moss PA, Taylor AM. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353:26-29, 1999.
22. Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster ADB, Yuille MAR. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature Genet 17:96-100, 1997.
23. Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 39: 573-583, 1986.
24. Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677, 1998.
25. Wright J, Teraoka S, Onengut S, Tolun A, Gatti RA, Ochs HD, Concannon P. A high frequency of distinct ATM mutations in ataxia-telangiectasia. Am J Hum Genet 59:839-846, 1996.
26. Castellvi-Bel S, Sheikhavandi S, Telatar M, Tai L-Q, Hwang M, Wang Z, Yang Z, Cheng R, Gatti RA. New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel strategy. Hum Mutat 14:156-162, 1999.
27. Teraoka S, Telatar M, Becker-Catania S, Liang T, Onegut S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P. Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and phenotypic consequences. Am J Hum Genet 64:1617-1631, 1999.
28. Watters D, Khanna K-K, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhand N, Farrel A, Ramsay J, Gatti RA, Lavin M. Cellular localization of the ataxia-telangiectasia (ATM) gene product and discriminate between mutated and normal forms. Oncogene 14:1911-1917, 1997.
29. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin MF. Interaction between ATM protein and c-abl in response to DNA damage. Nature 387:520-523, 1997.
30. Smith GCM, Cary RB, Lakin ND, Hann BC, Teo S-H, Chen DJ, Jackson SP. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci 96:11134-11139, 1999.
31. Hacia JG, Sun B, Hunt N, Edgemon K, Mosbrook D, Robbins C, Fodor SPA, Tagle DA, Collins FS. Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res 8:1245-1258, 1998.
32. Liu Q, Feng J, Buzin C, Wen C, Nozari G, Mengos A, Nguyen V, Liu J, Crawford L, Fujimura FK, Sommer SS. Detection of virtually all mutations - SSCP (DOVAM-S): A rapid method for mutation scanning with virtually 100% sensitivity. BioTechniques 26:932-938, 1999.